Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
male (10) 10
aged (8) 8
female (8) 8
clinical neurology (7) 7
index medicus (7) 7
stroke (7) 7
middle aged (6) 6
adult (5) 5
peripheral vascular disease (5) 5
treatment outcome (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
atorvastatin calcium (3) 3
cardiac & cardiovascular systems (3) 3
cholesterol - blood (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3) 3
risk (3) 3
risk factors (3) 3
stroke - prevention & control (3) 3
anticonvulsants - therapeutic use (2) 2
article (2) 2
atorvastatin (2) 2
double-blind method (2) 2
drug therapy, combination (2) 2
electroencephalography (2) 2
follow-up studies (2) 2
heptanoic acids - therapeutic use (2) 2
inhibitor (2) 2
ischemic attack, transient - complications (2) 2
ischemic attack, transient - drug therapy (2) 2
life sciences (2) 2
prognosis (2) 2
proportional hazards models (2) 2
prospective studies (2) 2
pyrroles - therapeutic use (2) 2
retrospective studies (2) 2
seizures (2) 2
statins (2) 2
stroke - complications (2) 2
stroke - drug therapy (2) 2
stroke - epidemiology (2) 2
[ sdv.ib ] life sciences [q-bio]/bioengineering (1) 1
activation (1) 1
acute disease (1) 1
acute ischemic-stroke (1) 1
adenosine - administration & dosage (1) 1
adenosine - adverse effects (1) 1
adenosine - analogs & derivatives (1) 1
adjuvants, immunologic - administration & dosage (1) 1
adjuvants, immunologic - adverse effects (1) 1
adolescent (1) 1
age factors (1) 1
amygdala - physiopathology (1) 1
angina (1) 1
angina, stable - epidemiology (1) 1
angiogenesis (1) 1
anticonvulsants - pharmacokinetics (1) 1
antiepileptic drugs (1) 1
arterial occlusive diseases - etiology (1) 1
arteries (1) 1
aspirin (1) 1
aspirin - administration & dosage (1) 1
aspirin - adverse effects (1) 1
atherosclerosis (1) 1
azd6140 (1) 1
bioengineering (1) 1
c-reactive protein (1) 1
carbamazepine (1) 1
carbamazepine - analogs & derivatives (1) 1
carbamazepine - metabolism (1) 1
carbamazepine - pharmacokinetics (1) 1
carbamazepine - therapeutic use (1) 1
carbamazepine-10,11-epoxide (1) 1
cardiac resynchronization therapy (1) 1
cardiovascular diseases (1) 1
cardiovascular diseases - mortality (1) 1
cardiovascular events (1) 1
cardiovascular physiological phenomena - drug effects (1) 1
care (1) 1
carotid (1) 1
carotid endarterectomy (1) 1
carotid stenosis (1) 1
carotid stenting (1) 1
case-control studies (1) 1
causes of (1) 1
cerebral hemorrhage - complications (1) 1
cerebral hemorrhage - diagnosis (1) 1
cerebral-ischemia (1) 1
child (1) 1
child, preschool (1) 1
children (1) 1
cholesterol (1) 1
chorea - complications (1) 1
chorea - diagnosis (1) 1
clarify registry (1) 1
clinical-outcomes (1) 1
clopidogrel (1) 1
cocaine (1) 1
cocaine - poisoning (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text ALternate Site Cardiac ResYNChronization (ALSYNC): A prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy
by Morgan, John M and Biffi, Mauro and Gellér, László and Leclercq, Christophe and Ruffa, Franco and Tung, Stanley and Defaye, Pascal and Yang, Zhongping and Gerritse, Bart and Van Ginneken, Mireille and Yee, Raymond and Jais, Pierre and ALSYNC Investigators
European Heart Journal, ISSN 0195-668X, 07/2016, Volume 37, Issue 27, pp. 2118 - 2127
Aims The ALternate Site Cardiac ResYNChronization (ALSYNC) study evaluated the feasibility and safety of left ventricular endocardial pacing (LVEP) using a... 
Heart failure | Left ventricular endocardial pacing | Safety | Prospective clinical trial | CARDIAC & CARDIOVASCULAR SYSTEMS | STIMULATION | EFFICACY | SINUS | MIDTERM FOLLOW-UP | HEART-FAILURE | RISK | TRIAL | STROKE | RHYTHM | LEAD | Heart Ventricles | Heart Failure | Treatment Outcome | Prospective Studies | Cardiac Resynchronization Therapy | Humans | Life Sciences | Bioengineering
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Results of the Intravascular Cooling in the Treatment of Acute Stroke 2 Trial (ICTuS-2)
by Lyden, Patrick and Hemmen, Thomas and Grotta, James and Rapp, Karen and Ernstrom, Karin and Rzesiewicz, Teresa and Parker, Stephanie and Concha, Mauricio and Syed, Hussain and Agarwal, Sachin and Meyer, Brett and Jurf, Julie and Altafullah, Irfan and Raman, Rema
Stroke, ISSN 0039-2499, 12/2016, Volume 47, Issue 12, pp. 2888 - 2895
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2)
by Lyden, Patrick and Hemmen, Thomas and Grotta, James and Rapp, Karen and Ernstrom, Karin and Rzesiewicz, Teresa and Parker, Stephanie and Concha, Mauricio and Hussain, Syed and Agarwal, Sachin and Meyer, Brett and Jurf, Julie and Altafullah, Irfan and Raman, Rema and Hess, Mary Jane and Mullin, Anthony and Jane Hess, Mary and Muranevici, Gabriela and Piantadosi, Bonnie and Jimenez-Maggiora, Gustavo and So, Jia-Shing and Jain, Sonia and Diringer, Michael and Derdeyn, Colin and Stern, Barney and Hamilton, Scott and Dietrich, Dalton and Becker, Kyra and Yenari, Midori and Dirnagl, Ulrich and Wijman, Christine and Chamorro, Ángel and Janis, Scott and Moy, Claudia and Lin, Felice and Song, Shlee and Schlick, Konrad and Khanolkar, Pooja and Edwards, Nancy J and Roldan, Ana and Wilson, Jeanette and Little, Amy and Lewis, Pam and Neil, William and Bruce, Nhu and Guzik, Amy and Sohdi, Ajeet and Herial, Nabeel and Ovbiagele, Bruce and Meyer, Dawn and Modir, Royya and Chavez, Ronelyn and Velazquez, Angela and Mayer, Stephan and Claassen, Jan and Falo, Cristina and Tafreshi, Gilda and Kelly, Nancy and Shell, Erin and Dugan, Guy and Kim, Elizabeth and Tanner, Amy and Michel, Patrik and Eskandari, Ashraf and Oddo, Mauro and Suys, Tamarah and Remillard, Suzette and Cordier, Maria and Brown, Robert and Jasak, Sara and McCullough, Louise and Brautigam, Robert and Alexandrov, Andrei and Sisson, April and Albright, Karen and Broessner, Gregor and Schmutzhard, Erich and Escioglou, Elissanet and Jones, William and Poisson, Sharon and Simpson, Jennifer and Shah, Qaisar and Jonczak, Karin and Bussinger, Patricia and Lewandowski, Christopher and Berry, Shannen and Lundell, AnneMarie and Miller, Joseph B and Cruz-Flores, Salvador and Holzer, Eve and Torretta, Susan and Brown, David and Heim, Laura and Smith, Carlos and Kelley, Chip and Greer, David and Marcolini, Evadne G and Gilmore, Emily J and Rutledge, Neil and McBee, Del and ... and Collaborators
Stroke, ISSN 0039-2499, 12/2016, Volume 47, Issue 12, pp. 2888 - 2895
BACKGROUND AND PURPOSE—Therapeutic hypothermia is a potent neuroprotectant approved for cerebral protection after neonatal hypoxia-ischemia and cardiac arrest.... 
therapeutics | pneumonia | hypothermia | intention to treat analysis | neuroprotection | stroke | ischemic stroke | C-REACTIVE PROTEIN | STATEMENT | METAANALYSIS | THROMBECTOMY | VOLUME | HOSPITAL CARDIAC-ARREST | CARE | CLINICAL NEUROLOGY | THERAPEUTIC HYPOTHERMIA | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | COMATOSE SURVIVORS | Single-Blind Method | Hypothermia, Induced - adverse effects | Follow-Up Studies | Outcome Assessment (Health Care) | Humans | Middle Aged | Male | Hypothermia, Induced - instrumentation | Hypothermia, Induced - methods | Hypothermia, Induced - standards | Aged, 80 and over | Female | Aged | Stroke - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Time From Symptoms to Carotid Endarterectomy or Stenting and Perioperative Risk
by Meschia, James F and Hopkins, L Nelson and Altafullah, Irfan and Wechsler, Lawrence R and Stotts, Grant and Gonzales, Nicole R and Voeks, Jenifer H and Howard, George and Brott, Thomas G
Stroke, ISSN 0039-2499, 12/2015, Volume 46, Issue 12, pp. 3540 - 3542
BACKGROUND AND PURPOSE—Prior meta-analysis showed that carotid endarterectomy benefits decline with increasing surgical delay following symptoms. For... 
carotid stenosis | humans | stroke | stents | endarterectomy, carotid | STENOSIS | PERIPHERAL VASCULAR DISEASE | endarterectomy | carotid | CLINICAL NEUROLOGY | Intraoperative Complications - diagnosis | Perioperative Care - trends | Perioperative Care - adverse effects | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Endarterectomy, Carotid - adverse effects | Time Factors | Intraoperative Complications - etiology | Female | Aged | Endarterectomy, Carotid - trends | Stents - trends | Stents - adverse effects | carotid endarterectomy | carotid stenting
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
by Goldstein, Larry B and Amarenco, Pierre and Zivin, Justin and Messig, Michael and Altafullah, Irfan and Callahan, Alfred and Hennerici, Michael and MacLeod, Mary J and Sillesen, Henrik and Zweifler, Richard and Welch, K Michael A and SPARCL Investigators and Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators
Stroke, ISSN 0039-2499, 11/2009, Volume 40, Issue 11, pp. 3526 - 3531
BACKGROUND AND PURPOSE—Laboratory experiments suggest statins reduce stroke severity and improve outcomes. The Stroke Prevention by Aggressive Reduction in... 
Stroke | Outcome | Statins | ICH | ACTIVATION | ANGIOGENESIS | TRANSIENT ISCHEMIC ATTACK | NITRIC-OXIDE SYNTHASE | stroke | CLINICAL NEUROLOGY | ATORVASTATIN | EXPERIMENTAL INTRACEREBRAL HEMORRHAGE | statins | NEUROGENESIS | PERIPHERAL VASCULAR DISEASE | SCALE | INHIBITOR | CEREBRAL-ISCHEMIA | outcome | Hypercholesterolemia - blood | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Cholesterol - blood | Humans | Middle Aged | Male | Treatment Outcome | Stroke - drug therapy | Hypercholesterolemia - drug therapy | Stroke - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Female | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Reply from the Authors
by Birnbaum, Gary and Altafullah, Irfan and Reder, Anthony
Neurology, ISSN 0028-3878, 06/2009, Volume 72, Issue 22, pp. 1965 - 1966
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Reply from the authors
by Birnbaum, Gary and Cree, Bruce and Altafullah, Irfan and Reder, Anthony
Neurology, ISSN 0028-3878, 09/2009, Volume 73, Issue 13, pp. 1078 - 1079
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
by Eisen, Alon and Bhatt, Deepak L and Steg, P. Gabriel and Eagle, Kim A and Goto, Shinya and Guo, Jianping and Smith, Sidney C and Ohman, E. Magnus and Scirica, Benjamin M and REACH Registry Investigators and the REACH Registry Investigators
Journal of the American Heart Association, ISSN 2047-9980, 10/2016, Volume 5, Issue 10, p. n/a
Background The extent to which angina is associated with future cardiovascular events in patients with coronary artery disease has long been debated. Methods... 
cardiovascular events | coronary artery disease | angina | Cardiovascular events | Coronary artery disease | Angina | CARDIAC & CARDIOVASCULAR SYSTEMS | OUTPATIENTS | MYOCARDIAL-ISCHEMIA | RISK | SYMPTOMS | RATES | HEART-DISEASE | SOUL | PECTORIS | CLARIFY REGISTRY | CLINICAL-OUTCOMES | United States - epidemiology | Myocardial Infarction - epidemiology | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Hospitalization - statistics & numerical data | Male | Case-Control Studies | Myocardial Revascularization - utilization | Angina, Stable - epidemiology | Cardiovascular Diseases - mortality | Female | Registries | Stroke - epidemiology | Aged | Coronary Artery Disease - epidemiology | Odds Ratio | Heart Failure - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)
by Easton, J Donald and Aunes, Maria and Albers, Gregory W and Amarenco, Pierre and Bokelund-Singh, Sara and Denison, Hans and Evans, Scott R and Held, Peter and Jahreskog, Marianne and Jonasson, Jenny and Minematsu, Kazuo and Molina, Carlos A and Wang, Yongjun and Wong, K.S Lawrence and Johnston, S Claiborne and Ameriso, Sebastiá F and Donnan, Geoffrey and Lemmens, Robin and Massaro, Ayrton and Titianova, Ekaterina and Hill, Michael D and Lavados, Pablo and Skoloudik, David and Röther, Joachim and Norbert, Szegedi and Agnelli, Giancarlo and Bornstein, Natan and Tanahashi, Norio and Góngora, Angel Arauz and Pretell, Edwin and San Jose, Maria Cristina Z and Czlonkowska, Anna and Bajenaru, Ovidiu and Stakhovskaya, Ludmila and Brozman, Miroslav and Kim, Jong-Sung and Wahlgren, Nils and Michel, Patrik and Lee, Tsong Hai and Suwanwela, Nijasri Charnnarong and Kutluk, Kursad and Moskovko, Sergii and Kasner, Scott and Laskowitz, Daniel and Clark, Wayne and Nguyen, Huy Thang and Ameriso, Sebastian and Lepera, Sandra and Romano, Marina and Paulon, David and Ioli, Pablo and Zurru, Cristina and Bruera, Guadalupe and Jure, Lorena and Klein, Francisco and Povedano, Guillermo and Levi, Christopher and Phan, Thanh and Markus, Romesh and Anderson, Craig and Sabet, Arman and Davis, Stephen and Lee, Andrew and Kleinig, Timothy and Wong, Andrew and Krause, Martin and Jannes, Jim and Wijeratne, Tissa and Hemelsoet, Dimitri and Peeters, André and Tack, Philippe and Vanacker, Peter and Laloux, Patrice and Van Landegem, William and Vanhooren, Geert and Desfontaines, Philippe and Van Orshoven, Marc and Oliveira, Fabio and Friedrich, Mauricio and Brondani, Rosane and Gagliardi, Rubens and Fabio, Soraia and Dracoulakis, Marianna and Bazan, Rodrigo and Marrone, Luiz and Pontes Neto, Octavio and Silva, Gisele and Kowacs, Pedro and Stamenova, Paraskeva and Daskalov, Marin and Staikov, Ivan and Baldaranov, Dimo and Maslarov, Dimitar and Lilovski, Hristo and Petkov, Plamen and Petrova, Neli and Mavrov, Radoslav and Markova, Veska and Petrova, Valeria and Beleva, Tanya and ... and SOCRATES Steering Comm and SOCRATES Steering Committee and Investigators and For the SOCRATES Steering Committee and Investigators
Circulation, ISSN 0009-7322, 09/2017, Volume 136, Issue 10, pp. 907 - 916
BACKGROUND:Patients with minor acute ischemic stroke or transient ischemic attack are at high risk for subsequent stroke, and more potent antiplatelet therapy... 
Platelet aggregation inhibitors | Aspirin | Ischemic attack | Stroke | Transient | Hemorrhage | AZD6140 | PLACEBO | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | RATIONALE | PREVENTION | P2Y RECEPTOR ANTAGONIST | stroke | CLOPIDOGREL | INHIBITION | ischemic attack | transient | platelet aggregation inhibitors | DOUBLE-BLIND | aspirin | PERIPHERAL VASCULAR DISEASE | MATCH | hemorrhage | Ischemic Attack, Transient - drug therapy | Purinergic P2Y Receptor Antagonists - administration & dosage | Humans | Stroke - complications | Male | Risk | Treatment Outcome | Stroke - drug therapy | Adenosine - administration & dosage | Aspirin - administration & dosage | Ischemic Attack, Transient - complications | Purinergic P2Y Receptor Antagonists - adverse effects | Aspirin - adverse effects | Adenosine - adverse effects | Adenosine - analogs & derivatives | Female | Aged | Hemorrhage - chemically induced | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
by Sillesen, Henrik and Albers, Gregory and Altafullah, Irfan and Benavente, Oscar and Book, Diane and Broderick, Joseph and Calder, Christopher and Callahan, Alfred S and Carlini, Walter and Chaturvedi, Seemant and Chippendale, Thomas and Clark, Wayne and Collins, Greg and Coull, Bruce and Davis, Patricia and Devlin, Thomas and Dick, Arthur R and Dirr-Ledbetter, Lucy Younger and Dooneief, George and Duff, R. Scott and Estronza, Nordeli and Forteza, Alejandro and Frankel, Michael R and Frey, James L and Friday, Gary and Goldstein, Jerome and Goldstein, Steven and Graham, Gleen and Harper, Wayne and Harris, Jonathan and Hendin, Barry and Hess, David C and Hinton, Richard and Hollander, Joshua and Hsu, Chung Y and Hughes, Richard L and Kasner, Scott and Kent, T.A and Kim, Lance and Kirshner, Howard and LaMonte, Marian and Levin, Kenneth and Libman, Richard and McDowell, Paul and McGee, Francis E and Meyer, Brett and Minagar, Alireza and Munschauer, Frederick E and Munson, Richard and Nash, Marshall and Orr, Sean C and Ratinov, Gerald and Salanga, Virgilio and Sen, Souvik and Silliman, Scott and Singer, Richard and Smith, Don and Sullivan, Herman and Thaler, David and Tietjen, Gretchen and Tuchman, Michael and Uskavitch, David and Verro, Piero and Vicari, Ralph and Weinstein, Richard and Wilterdink, Janet and Zweifler, Richard and Beaudry, Michael and Cote, Robert and Hoyte, Keith and Lebrun, Louise-Helene and Norris, John and Selchen, Daniel and Shuaib, Ashfaq and Simard, Denis and Spence, David and Teal, Philip and Winger, Michael and Schmidt, Reinhold and Pramsohler, Bruno and Schmidauer, Christoph and Kaste, Markku and Sivenius, Juhani and Wagner, Anna and Terent, Andreas and Amarenco, Pierre and Milandre, Loic and Chollet, Francois and de Broucker, Thomas and Moulin, Thierry and Roullet, Etienne and Leys, Didier and Mahagne, Marie-Helene and Hennerici, Michael and Heiss, W.D and Busse, Otto and Haberl, Roman and Harms, L and Diener, C and Hamann, G and ... and SPARCL Investigators
Cerebrovascular Diseases, ISSN 1015-9770, 09/2003, Volume 16, Issue 4, pp. 389 - 395
Evidence suggests that statin therapy reduces the risk of stroke in patients with coronary heart disease (CHD), but its benefit for patients with... 
Original Paper | Atorvastatin | Stroke | Statin | Cholesterol | Lipid | LOVASTATIN | SERUM-CHOLESTEROL | ATHEROSCLEROSIS | stroke | atorvastatin | lipid | STATINS | CLINICAL NEUROLOGY | ARTERIES | statin | RISK-FACTOR | MEN | cholesterol | PERIPHERAL VASCULAR DISEASE | PRAVASTATIN | CORONARY-HEART-DISEASE | INHIBITOR | Stroke - prevention & control | Prospective Studies | Double-Blind Method | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Secondary Prevention | Patient Selection | Randomized Controlled Trials as Topic | Atorvastatin Calcium | Multicenter Studies as Topic | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Endpoint Determination | Aged, 80 and over | Adult | Female | Aged | Pyrroles - therapeutic use | Research Design
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Phase 2/3 study of intravenous thrombolysis and hypothermia for acute treatment of ischemic stroke (ICTuS 2/3)
by Hemmen, Thomas and Rapp, Karen and Raman, Rema and Concha, Mauricio and Brössner, Gregor and Schmutzhard, Erich and Tafreshi, Gilda and Misra, Vivek and Cruz-Flores, Salvador and Kollmar, Rainer and Brown, David and Altafullah, Irfan and Michel, Patrik and Alexandrov, Andrei and Smith, Carlos and Jurf, Julie and Hess, Mary and Grotta, James and Lyden, Patrick
Critical Care, ISSN 1364-8535, 2012, Volume 16 Suppl 2, Issue Suppl 2, pp. A13 - A13
Meeting Abstract
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis
by Salvatore, Elena and Morra, Vincenzo Brescia and Orefice, Giuseppe
Neurology, ISSN 0028-3878, 2009, Volume 73, Issue 13, pp. 1078 - 1078
CLINICAL NEUROLOGY | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Interferon-beta - administration & dosage | Multiple Sclerosis, Relapsing-Remitting - pathology | Adjuvants, Immunologic - administration & dosage | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Heptanoic Acids - adverse effects | Disease Progression | Adjuvants, Immunologic - adverse effects | Atorvastatin Calcium | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Interferon beta-1a | Interferon-beta - adverse effects | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Pyrroles - adverse effects | Drug Therapy, Combination | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
by Callahan, Alfred and Amarenco, Pierre and Goldstein, Larry B and Sillesen, Henrik and Messig, Mike and Samsa, Gregory P and Altafullah, Irfan and Ledbetter, Lucy Y and MacLeod, Mary J and Scott, Russell and Hennerici, Michael and Zivin, Justin A and Welch, K. Michael A and SPARCL Investigators, for the and SPARCL Investigators
Archives of Neurology, ISSN 0003-9942, 10/2011, Volume 68, Issue 10, pp. 1245 - 1251
OBJECTIVE To perform a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, which tested the effect of... 
Confidence Intervals | Lipoproteins, HDL - blood | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Stroke - complications | Male | Ischemic Attack, Transient - complications | Young Adult | Aged, 80 and over | Adult | Cardiovascular Physiological Phenomena - drug effects | Female | Stroke - epidemiology | Retrospective Studies | Pyrroles - therapeutic use | Diabetes Mellitus, Type 2 - complications | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Risk Factors | Proportional Hazards Models | Metabolic Syndrome - complications | Atorvastatin Calcium | Ischemic Attack, Transient - epidemiology | Stroke - etiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Lipoproteins, LDL - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Cocaine-induced seizures
by Pascual-Leone, Alvaro and Dhuna, Anil and Altafullah, Irfan and Anderson, David C
Neurology, ISSN 0028-3878, 03/1990, Volume 40, Issue 3, pp. 404 - 407
We retrospectively studied 474 patients seen at Hennepin County Medical Center because of medical complications related to acute cocaine intoxication. Of the... 
CLINICAL NEUROLOGY | Epilepsies, Partial - chemically induced | Prognosis | Age Factors | Humans | Risk Factors | Epilepsy, Post-Traumatic - physiopathology | Anticonvulsants - therapeutic use | Male | Electroencephalography | Epilepsy, Post-Traumatic - drug therapy | Seizures - chemically induced | Cocaine - poisoning | Subarachnoid Hemorrhage - physiopathology | Sex Factors | Adult | Female | Retrospective Studies
Journal Article
Details down arrow
15. Full Text Putaminal hemorrhage accompanied by hemichorea-hemiballism
by Altafullah, Irfan and Altafullah, I and Pascual-Leone, A and Pascual-Leone, Alvaro and Duvall, K and Duvall, Kathy and Anderson, David C and Anderson, D.C and Taylor, S and Taylor, Saul
Stroke, ISSN 0039-2499, 1990, Volume 21, Issue 7, pp. 1093 - 1094
Humans | Movement Disorders - diagnosis | Male | Tomography, X-Ray Computed | Functional Laterality | Putamen | Syndrome | Cerebral Hemorrhage - diagnosis | Movement Disorders - complications | Magnetic Resonance Imaging | Chorea - complications | Aged | Chorea - diagnosis | Cerebral Hemorrhage - complications
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
by Alfred Callahan and Pierre Amarenco and Larry B Goldstein and Henrik Sillesen and Mike Messig and Gregory P Samsa and Irfan Altafullah and Lucy Y Ledbetter and Mary J MacLeod and Russell Scott and Michael Hennerici and Justin A Zivin and K Michael A Welch
Archives of Neurology, ISSN 0003-9942, 10/2011, Volume 68, Issue 10, p. 1245
  To perform a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, which tested the effect of treatment... 
Stroke | Medical treatment | Regression analysis | Diabetes | Metabolic syndrome
Journal Article
Details down arrow
17. Focal Medial Temporal Lobe Spike‐Wave Complexes Evoked by a Memory Task
by Altafullah, I and Altafullah, Irfan and Halgren, Eric and Halgren, E
Epilepsia, ISSN 0013-9580, 1988, Volume 29, Issue 1, pp. 8 - 13
Several factors are known to modulate the occurrence of interictal spike-wave complexes (SWC). During performance of a recent memory task by a patient with... 
Complex partial seizures | Epilepsy | Memory | Neurosurgery | Depth electrodes | Hippocampus | Seizures | Amygdala - physiopathology | Temporal Lobe - physiopathology | Humans | Epilepsy, Temporal Lobe - physiopathology | Electrodes, Implanted | Electroencephalography | Psychological Tests | Hippocampus - physiopathology
Journal Article
Details down arrow
18. Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
by Callahan, Alfred |o and Amarenco, Pierre and Goldstein, Larry B and Sillesen, Henrik and Messig, Mike and Samsa, Gregory P and Altafullah, Irfan and Ledbetter, Lucy Y and MacLeod, Mary J and Scott, Russell and Hennerici, Michael and Zivin, Justin A and Welch, KMichael A
Archives of Neurology, ISSN 0003-9942, 01/2011, Volume 68, Issue 10, pp. 1245 - 1251
OBJECTIVE: To perform a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, which tested the effect of... 
Journal Article
Details down arrow